Entrada Therapeutics (TRDA) vs Whitehawk Therapeutics (WHWK)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Whitehawk Therapeutics (WHWK) has outperformed Entrada Therapeutics (TRDA) over the past year, gaining 53.6% versus a loss of 4.1%. Entrada Therapeutics is the larger company by market cap ($211.4 million vs $198.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | TRDA | WHWK |
|---|---|---|
| Share price | $5.43 | $3.48 |
| Market cap | $211.43M | $198.39M |
| 1-day change | -3.21% | +2.05% |
| YTD return | -45.43% | +40.91% |
| 1-year return | -4.10% | +53.60% |
| 5-year return | — | -87.47% |
| EPS (TTM) | $-3.96 | $-1.14 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $16.45 | $5.50 |
| 52-week low | $5.15 | $1.87 |
| Distance from 52-week high | -66.99% | -36.67% |
| Analyst consensus | none | buy |
| Avg. price target upside | +249.91% | +121.55% |
| Average volume | 359.01K | 371.36K |
| Shares outstanding | 38.94M | 57.01M |
| Employees | 152 | 32 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- WHWK has outperformed TRDA by 57.7 percentage points over the past year.
About Entrada Therapeutics
TRDA stock →Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle, therapeutic candidates are based on a novel therapeutic; a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 152 employees
About Whitehawk Therapeutics
WHWK stock →Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer.
Health Care · Biotechnology: Pharmaceutical Preparations · 32 employees
TRDA vs WHWK FAQ
Which is bigger, Entrada Therapeutics or Whitehawk Therapeutics?
Entrada Therapeutics (TRDA) is larger, with a market capitalization of $211.43M compared with $198.39M for Whitehawk Therapeutics (WHWK).
Which stock has performed better over the past year, TRDA or WHWK?
WHWK returned +53.60% over the past 12 months, compared with -4.10% for TRDA (price return, excluding dividends). Past performance does not predict future results.
Are Entrada Therapeutics and Whitehawk Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.